[Dopamine and abnormal movements].
D001545:Benserazide / Q000494:pharmacology; D001835:Body Weight; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004576:Electromyography; D007839:Functional Laterality; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy; D009069:Movement Disorders / Q000139:chemically induced* / Q000503:physiopathology / Q000628:therapy; D010300:Parkinson Disease / Q000188:drug therapy; D013788:Thalamus / Q000601:surgery; D013997:Time Factors; D014103:Torticollis / Q000188:drug therapy; D014202:Tremor / Q000188:drug therapy
D004295:Dihydroxyphenylalanine; D001545:Benserazide; D002262:Carboxy-Lyases
Dopamine et mouvements anormaux.